Besides, MALAT1 could bind miR-200s to regulate ZEB2 in ccRCC [26], while LncRNA-ATB could regulate ZEB1 and ZEB2 by competitively binding the miR-200s to control EMT and invasion in hepatoma cells [27]. The gene discussed is ZEB2; the disease is nonpapillary renal cell carcinoma.